Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial.

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide and leuprolide,

The hospital is the first in Baton Rouge to offer Aquablation therapy with an AI-powered robotic system to treat benign prostatic hyperplasia (BPH), a condition that affects about half of men over the age of 50. BPH, more commonly known as an enlarged prostate, is a common condition that can make everyday life more challenging.